Word: biotech
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...overhaul the nation's health-care system. It's understandable the drugmakers would want a roll-call accounting of who their friends and enemies are, considering the size of the investment they are making on Capitol Hill: in the first six months of this year alone, drug and biotech companies and their trade associations spent more than $110 million - that's about $609,000 a day - to influence lawmakers, according to figures compiled by the nonpartisan watchdog group Center for Responsive Politics. The drug industry's legion of registered lobbyists numbers 1,228, or 2.3 for every member of Congress...
...After obtaining patents, Harvard licenses a number of the technologies it develops in its labs, such as organic compounds, vaccines, and diagnostics, to biotech and pharmaceutical companies for development into finished products. At present, there is no institutionalized mechanism to guarantee that drugs created from university research can be produced generically. Allowing generic production breaks the temporary monopoly a pharmaceutical company holds on a product that is guaranteed by its patent. With more companies able to produce a product, free-market competition drives down its price, and as its cost decreases, more people gain access to the drug. At present...
...This system must change. Without a standardized means to require generic production of certain technologies, Harvard effectively endorses the needless death and suffering of millions of people in the developing world. Instead, when it licenses a compound to a biotech or pharmaceutical company, the university should mandate that the drug created from that compound be allowed to be produced generically in developing countries, a move that would inherently lower the drug’s price...
...ivory-tower ingenue. "Energy," he says, "is all about money." He cut his teeth in the entrepreneurial culture of Bell Labs and spent the rest of his career around Silicon Valley; he's served on the boards of a battery company, a semiconductor firm and two biotech start-ups. In his last job, he shook up the bureaucracy of DOE's Lawrence Berkeley National Laboratory (LBNL) to tackle real-world energy problems, while becoming a leading expert on energy innovation. "He's brilliant, and he understands the full breadth of the energy portfolio," says Ralph Cavanagh, co-director...
...Similar efforts are being made across the island. In Kaohsiung, the government in 2008 opened a software park to spur tech start-ups alongside the city's traditional export factories. Nationally, Ma's administration has targeted six "flagship" industries for investment and development: biotech, health care, high-end agriculture, tourism, green energy, and creative and cultural businesses such as traditional arts and pop music. The government intends to support these sectors by providing financing, improving the capabilities of state research institutes and other measures. "We are keenly aware these industries in five to 10 years will be the major industries...